Gastrografin, 660mg/ml and 100mg/ml Oral and Rectal Solution Ireland - English - HPRA (Health Products Regulatory Authority)

gastrografin, 660mg/ml and 100mg/ml oral and rectal solution

bayer limited - sodium amidotrizoate; amidotrizoate meglumine; amidotrizoic acid; meglumine - oral/rectal solution - 660 and 100 milligram(s)/millilitre - watersoluble, hepatotropic x-ray contrast media; sodium iopodate

ORAGRAFIN SODIUM 0.5GM CAPSULE Canada - English - Health Canada

oragrafin sodium 0.5gm capsule

bracco imaging canada - ipodate sodium - capsule - 500mg - ipodate sodium 500mg - roentgenography

CHOLOGRAFIN MEGLUMINE INJ LIQUID Canada - English - Health Canada

cholografin meglumine inj liquid

squibb canada inc., division of bristol-myers squibb canada inc. - meglumine iodipamide - liquid - 52% - meglumine iodipamide 52% - roentgenography

TELEPAQUE TAB TABLET Canada - English - Health Canada

telepaque tab tablet

sterling winthrop inc. - iopanoic acid - tablet - 500mg - iopanoic acid 500mg - roentgenography

TELEPAQUE TAB 500MG TABLET Canada - English - Health Canada

telepaque tab 500mg tablet

sanofi canada, inc. - iopanoic acid - tablet - 500mg - iopanoic acid 500mg - roentgenography

TELEPAQUE  -  TABLET - 500MG Canada - English - Health Canada

telepaque - tablet - 500mg

nycomed imaging a.s. - iopanoic acid - tablet - 500mg - iopanoic acid 500mg - roentgenography

CHOLOGRAFIN MEGLUMINE INJ. - LIQ IV LIQUID Canada - English - Health Canada

cholografin meglumine inj. - liq iv liquid

bracco imaging canada - meglumine iodipamide - liquid - 52% - meglumine iodipamide 52% - roentgenography

Biliscopin For Infusion 10.5g/100mL injection bottle Australia - English - Department of Health (Therapeutic Goods Administration)

biliscopin for infusion 10.5g/100ml injection bottle

bayer australia ltd - iotroxate meglumine, quantity: 105.46 mg/ml - injection, solution - excipient ingredients: sodium calcium edetate; sodium bicarbonate; sodium chloride; water for injections - biliscopin for infusion is indicated for radiological examination of hepatic and biliary ducts and gallbladder when examination by oral technique is unsuccessful or inappropriate.

Viracept European Union - English - EMA (European Medicines Agency)

viracept

roche registration ltd. - nelfinavir - hiv infections - antivirals for systemic use - viracept is indicated in antiretroviral combination treatment of human-immunodeficiency-virus (hiv-1)-infected adults, adolescents and children of three years of age and older.in protease-inhibitor (pi)-experienced patients, the choice of nelfinavir should be based on individual viral resistance testing and treatment history.